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Abstract
Purpose Semiquantitative analysis of myocardial perfusion
scintigraphy (MPS) has reduced inter- and intraobserver
variability, and enables researchers to compare parameters
in the same patient over time, or between groups of
patients. There are several software packages available that
are designed to process MPS data and quantify parameters.
In this study the performances of two systems, quantitative
gated SPECT (QGS) and 4D-MSPECT, in the processing of
clinical patient data and phantom data were compared.
Methods The clinical MPS data of 148 consecutive patients
were analysed using QGS and 4D-MSPECT to determine the
end-diastolic volume, end-systolic volume and left ventricular
ejection fraction. Patients were divided into groups based on
gender, body mass index, heart size, stressor type and defect
type.TheAGATEdynamicheartphantomwasusedtoprovide
reference values for the left ventricular ejection fraction.
Results Although the correlations were excellent (correlation
coefficients 0.886 to 0.980) for all parameters, significant
differences (p<0.001) were found between the systems.
Bland-Altman plots indicated that 4D-MSPECT provided
overall higher values of all parameters than QGS. These
differences between the systems were not significant in
patients with a small heart (end-diastolic volume <70 ml).
Other clinical factors had no direct influence on the
relationship. Additionally, the phantom data indicated good
linear responses of both systems.
Conclusion The discrepancies between these software
packages were clinically relevant, and influenced by heart
size. The possibility of such discrepancies should be taken
into account when a new quantitative software system is
introduced, or when multiple software systems are used in
the same institution.
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Introduction
In addition to visual interpretation of myocardial perfusion
scintigraphy (MPS) data, quantitative software packages are
used to support semiquantitative analysis of the data.
Generally, these tools provide volumetric parameters such
as left ventricular ejection fraction (LVEF), end-systolic
volume (ESV) and end-diastolic volume (EDV). Addition-
ally regional parameters, such as wall thickening, wall
motion, and perfusion scores can be produced by most
software packages. The introduction of these quantitative
parameters has enabled researchers to compare parameters
in one patient over time, or between groups of patients [1].
Although quantitative analysis improves accuracy and
reduces inter- and intraobserver variability, there are also
some important factors that can influence the performance
of these software packages. For instance, the ability of a
software tool to produce accurate and reproducible param-
eter values relies predominantly on its ability to determine
the myocardial borders. In acquisitions in healthy humans
B. J. van der Veen (*): P. Dibbets-Schneider: M. P. M. Stokkel
Department of Nuclear Medicine,
Leiden University Medical Center,
2300 RC Leiden, The Netherlands
e-mail: b.j.van_der_veen@lumc.nl
M. P. M. Stokkel
e-mail: m.p.m.stokkel@lumc.nl
A. J. Scholte
Department of Cardiology, Leiden University Medical Center,
Leiden, The Netherlands
Eur J Nucl Med Mol Imaging (2010) 37:1736–1744
DOI 10.1007/s00259-010-1465-6detection of the myocardial border is challenging because
of the relatively low resolution of the gamma camera
compared to the thickness of the myocardium. Additionally,
factors such as Compton photon scatter, attenuation,
extracardiac activity and natural variations in orientation
of the heart contribute to the complexity of border
detection. Acquisitions in patients can also include extensive
perfusion and functional abnormalities. Thus, a quantitative
software package should provide a robust framework that
produces correct estimates of the various parameter values in
almost all situations.
Within the Nuclear Department of the Leiden University
Medical Centre two software systems, quantitative gated
SPECT (QGS) from Cedars-Sinai Medical Center [2] and the
4D-MSPECT software package of Invia Medical Imaging
Solutions [3] (University of Michigan), are available. Both
quantitative software packages are commonly used and are
well validated for their clinical use [4–7]. Although previous
studies have indicated a good correlation for EDV, ESV and
LVEF between these two packages, it seems that the values
are not exchangeable. So the main objective of this study
was to compare the two software packages with respect to
their performance on clinical patient data. In order to study
the differences between the two software packages, various
clinical factors were identified that could influence the
relationship between the packages. A phantom study was
performed to provide an absolute reference frame to compare
the two systems with respect to linearity.
Materials and methods
Patient population
Consecutive patients referred for
99mTc-tetrofosmin MPS
with adenosine- or exercise-induced stress during the period
November 2008 to January 2009 were prospectively
included (n=150). All acquisitions were analysed by the
QGS and 4D-MSPECT packages. Poststress and rest
acquisitions were also evaluated visually and scored as
‘normal’, ‘reversible’, ‘persistent’ or ‘combined reversible
and persistent’. Clinical information with respect to relevant
medication, risk factors and reason for MPS were gathered.
Gated-SPECT acquisition and analysis
In the present study we used a 2-day stress/rest protocol,
with the stress test performed on day 1 and the rest test
performed on day 2. Patients were instructed to stop β-
blockers and calcium antagonists 48 h and caffeine-
containing products 12 h before stress testing. The patients
underwent physical exercise limited by symptoms, or, when
contraindications to exercise were present, adenosine-
induced stress using a standard infusion rate of 140 µg/kg
per minute. Injection of the radiopharmaceutical was done
at peak exercise, or in the third minute of pharmacological
stress induction. Acquisition, both after stress and at rest,
was performed with a triple-headed camera system (CGA
9300; Toshiba, Tokyo, Japan) 45 min after injection of
500 MBq of
99mTc-tetrofosmin. Images were acquired over
360° (6° per step, 40 s per step). Automatic ECG gating
was applied on the R-R interval with 16 frames per cardiac
cycle, with a tolerance window of 50%.
Data were prefiltered using a Butterworth filter (eighth
order, cut-off frequency 0.26 Hz), and reconstructed as
transaxial images using a filtered back-projection algo-
rithm. No attenuation or scatter correction was applied.
Acquisitions were projected as tomographic slices in the
short-axis and vertical/horizontal long-axis directions for
visual analysis. Quantitative values were automatically
generated for EDV, ESV and LVEF by QGS (version 2.0
rev A) and 4D-MSPECT (version 5.2 SP 2). Heart size was
estimated using the left ventricular end-diastolic volume.
Phantom study
The Amsterdam gated (AGATE) dynamic cardiac phantom
(model 830.100; VANDERWILT techniques, Boxtel, The
Netherlands) was used as a reference for the LVEF. The
phantom consists of a water-filled torso in which a twin
membrane lumen filled with water and 10 MBq
99mTc-
pertechnetate is placed. The cardiac volume is automatically
regulated by a computer-controlled pumping system
(Fig. 1). The system produces ECG signals in agreement
with the diastolic and systolic phases of the heart. In this
study the cardiac output was varied at a constant heart rate
of 80 beats per minute to provide a range of LVEF values.
The MPS acquisitions of the phantom were analysed by the
QGS and 4D-MSPECT packages.
Statistical methods
All statistical analyses were performed using SPSS
v16.0. Differences in EVD, ESD and LVEF between
the packages were tested for significance using the
paired Student’s t-test, with p<0.05 considered signifi-
cant. The agreement between the systems was evaluated
using Bland-Altman graphs. Linear regression analysis
was performed on the phantom data to provide informa-
tion about the linearity between the two software packages
over a range of LVEF values. Multiple linear regression
analysis was performed to identify the main factors
explaining differences in ESV, EDV and LVEF derived
by the two software packages. Significant factors were
used to further identify the relationship between the QGS
and 4D-MSPECT packages.
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One patient had to be excluded during the study because
4D-MSPECT could not provide accurate border detection,
another patient had to be excluded because neither
package was able to provide accurate border detection.
Details of the included population (n=148) can be found
in Table 1.
Differences and agreement based on clinical patient data
The clinical patient dataset was used to calculate the EDV,
ESV and LVEF using 4D-MSPECT and QGS (Table 2).
Mean parameter values are shown, supplemented with the
results of a paired Student’s t-test analysis calculating the
mean differences between the values calculated by the two
packages. Although the correlations were high (correlation
coefficients ranging from 0.886 to 0.980 for the different
parameters), the EDV, ESVand LVEF calculated by the two
software packages differed significantly (p<0.001). Addi-
tionally, a Bland-Altman analysis was performed for rest
and poststress acquisitions (Fig. 2). The limits for EDV,
ESVand LVEF in the rest acquisitions were −11.8–66.4 ml
(mean 27.3 ml), −29.3–46.9 ml (mean 8.8 ml) and −11.7–
19.7% (mean 4.0%), respectively. The limits for EDV, ESV
and LVEF in the poststress acquisitions were −15.3–
69.7 ml (mean 27.2 ml), −29.7–47.3 ml (mean 8.5 ml)
and −10.5–19.1% (mean 4.3%), respectively. A positive
shift of the mean-line from the line of equality is apparent
in all figures, indicating that 4D-MSPECT provided higher
values then QGS for all parameters. Furthermore, differ-
ences between the software packages increased with
increasing average heart size.
Multivariate analysis
Stepwise multiple regression analysis identified the most
important factors explaining the differences in EDV, ESV
and LVEF between the packages. Factors included in the
analysis were relevant risk factors, reason for MPS, stressor
type, and average volumetric measurements. The average
volumetric measurements were determined by calculating
the means of the QGS and 4D-MSPECT values.
The factors that were able to explain the difference
between the ESV values determined by two packages were
average ESVrest (p<0.001), gender (p=0.034) and BMI
(rest and poststress, p=0.036 and p=0.018, respectively).
Table 1 Patient characteristics
Characteristic Value
Risk factors Age (years) 60.6±10.2
BMI (kg/m
2) 27.6±4.4
Male gender, n (%) 105 (70.9)
Smoker, n (%) 57 (38.5)
Alcohol abuser, n (%) 14 (9.5)
Hypercholesterolaemia, n (%) 57 (38.5)
Hypertension, n (%) 81 (54.7)
Positive family history, n (%) 50 (33.7)
Diabetic, n (%) 33 (22.2)
History of CAD or infarction, n (%) 83 (56.1)
Medication β-Blocker, n (%) 107 (72.3)
Calcium antagonist, n (%) 13 (8.8)
ACE inhibitor, n (%) 67 (45.2)
Reason for MPS Chest pain, n (%) 24 (16.2)
Proven/suspected CAD or
infarction, n (%)
85 (57.4)
Abnormal ECG or stress test, n (%) 15 (10.1)
Stem cell protocol, n (%) 10 (6.7)
Preoperative screening, n (%) 7 (4.7)
Other, n (%) 7 (4.7)
MPS results Exercise as stressor, n (%) 77 (52.0)
Normal scan, n (%) 31 (20.9)
Average rest ESV (ml) 72.0±65.7
Average rest EDV (ml) 138.2±71.7
Average rest LVEF (%) 54.6±15.9
Fig. 1 AGATE heart phantom
with twin membrane lumen rep-
resenting the myocardial wall
and LV lumen placed in a water-
filled Plexiglas torso. The LV
volume is adjusted by a
computer-controlled pumping
system to produce different
LVEF values
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of EDV, ESV and LVEF calcu-
lated by the two software
systems for the rest and
poststress acquisitions. Bland-
Altman analysis indicates the
difference of the estimates
obtained by the two systems
(4D-MSPECT − QGS) in
relation to the average of these
estimates. The red dashed lines
represent the Bland-Altman
limits (±1.96×SD), the red solid
lines represent the mean differ-
ences, and the blue dashed lines
are the lines of equality
Rest acquisitions Poststress acquisitions
Mean Difference p value Mean Difference p value
EDV (ml)
QGS 124.6±66.2 27.3±19.5 <0.001* 122.1±66.8 27.2±21.3 <0.001*
4D-MSPECT 151.9±78.0 149.3±82.0
ESV (ml)
QGS 67.7±61.0 8.8±19.1 <0.001* 65.6±62.2 8.5±19.1 <0.001*
4D-MSPECT 76.4±71.3 74.1±75.5
LVEF (%)
QGS 52.6±16.0 4.0±7.9 <0.001* 54.0±17.5 4.3±7.4 <0.001*
4D-MSPECT 56.6±16.7 58.3±17.6
Table 2 EDV, ESV and LVEF
calculated by 4D-MSPECT
and QGS
*p<0.05, paired Student’s t-test.
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(rest and poststress, p=0.002 and p=0.005, respectively)
and average ESVrest (p<0.001). The difference in LVEF
values was explained by average ESVrest (p=0.012),
average EDVrest (p=0.048), small heart size (rest and
poststress p=0.001 and p=0.002, respectively) and stressor
type (p=0.032). These factors were used to produce
subgroups for further analysis.
Influence of various factors
Previous studies have shown that QGS overestimates LVEF
in smaller hearts (EDV <70 ml), so the study population was
subdivided using this cut-off value [8, 9]. The eventual
distribution of the population resulted in the following
subgroups; gender (104 male, 44 female), stressor type (77
adenosine, 71 exercise), heart size (15 EDV ≤70 ml, 133
EDV >70 ml), defect type (31 normal, 15 reversible, 63
persistent, 39 combination) and BMI (105 <30 kg/m
2,
43 ≥30 kg/m
2). The paired differences between the values
in each group determined by the two packages are
presented in Table 3. Since the observed differences were
significant over the entire population, the nonsignificant
differences (p>0.05) are marked in this table, as they
indicate a deviation from the observed trend. Overall, we
found a significant difference between the EDV values
(p<0.001) determined by the two packages in all subgroups
and in both rest and poststress acquisitions. A relatively
smaller difference was found between the values deter-
mined by the two packages in the groups with a small heart
(EDVrest 15.1±5.3 ml, EDVstress 14.5±5.4 ml) as well as
in the group with normal perfusion (EDVrest 19.5±10.4 ml,
EDVstress 17.9±11.1 ml), compared to the difference in
the overall population (EDVrest 27.3±19.5ml, EDVstress
27.2±21.3 ml).
Regarding ESV, the difference between the values
determined by QGS and 4D-MSPECT was not significant
in the normal and reversible perfusion subgroups. In
Table 3 Influence of various factors on differences in EDV, ESV and LVEF determined by QGS and 4D-MSPECT (means±SD)
Factor Acquisition Difference in EDV (ml) Difference in ESV (ml) Difference in LVEF (%)
Mean p value Mean p value Mean p value
Gender Male Rest 28.8±21.0 <0.001 9.6±20.7 <0.001 4.6±7.2 <0.001
Female Rest 23.9±15.1 <0.001 6.8±14.5 0.003 2.5±9.2 0.073
a
Male Stress 29.3±23.5 <0.001 9.9±20.7 <0.001 4.7±6.5 <0.001
Female Stress 22.2±13.7 <0.001 5.3±14.5 0.020 3.3±9.2 0.022
Defect type Normal Rest 19.5±10.4 <0.001 2.0±8.7 0.216
a 3.2±11.0 0.116
a
Reversible Rest 22.8±10.4 <0.001 3.7±6.9 0.059
a 4.4±7.1 0.032
Persistent Rest 31.4±24.6 <0.001 13.4±24.7 <0.001 3.6±6.7 <0.001
Combination Rest 28.7±16.6 <0.001 8.6±15.8 0.002 5.2±6.9 <0.001
Normal Stress 17.9±11.1 <0.001 0.8±9.3 0.633
a 4.1±9.5 0.024
Reversible Stress 22.8±8.8 <0.001 2.5±8.6 0.272
a 5.5±7.2 0.010
Persistent Stress 31.5±28.1 <0.001 13.5±24.2 <0.001 3.7±6.7 <0.001
Combination Stress 29.2±14.8 <0.001 8.8±16.0 0.001 5.0±6.7 <0.001
Stressor type Adenosine Rest 29.1±14.8 <0.001 8.8±20.9 <0.001 4.9±8.8 <0.001
Exercise Rest 25.4±16.4 <0.001 8.7±16.9 <0.001 3.1±6.7 <0.001
Adenosine Stress 30.4±25.5 <0.001 10.6±22.8 <0.001 4.8±8.8 <0.001
Exercise Stress 23.8±14.8 <0.001 6.2±13.8 <0.001 3.7±6.2 <0.001
Heart size (EDV, ml) ≤70 Rest 15.1±5.3 <0.001 3.1±4.6 0.005 −1.2±10.3 0.647
a
>70 Rest 28.7±19.9 <0.001 9.3±20.0 <0.001 4.6±7.4 <0.001
≤70 Stress 14.5±5.4 <0.001 3.1±4.6 0.020 −0.2±7.7 0.901
a
>70 Stress 28.6±22.0 <0.001 9.1±20.0 <0.001 4.8±7.2 <0.001
BMI (kg/m
2) <30 Rest 24.6±17.3 <0.001 6.8±18.2 <0.001 4.7±8.4 <0.001
≥30 Rest 33.9±23.0 <0.001 13.6±20.4 <0.001 2.3±6.2 0.013
<30 Stress 26.2±23.3 <0.001 7.5±20.7 <0.001 5.1±7.8 <0.001
≥30 Stress 29.7±15.3 <0.001 11.0±14.3 <0.001 2.3±5.8 0.017
Paired Student’s t-test was used to determine the significance of the differences (p values) between the 4D-MSPECT and QGS estimates.
aNonsignificant difference (p>0.05).
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between the groups with a small heart (ESVrest and
ESVstress 3.1±4.6 ml), compared to the overall population
(ESVrest 8.8±19.1 ml, ESVstress 8.5±19.1 ml). Finally,
the LVEF values determined by the two packages were
significantly different in almost all groups, with the
exception of the group with a small heart, normal perfusion
and female gender.
Phantom study
There was a strong linear relationship between the software
package estimates andthephantomdataovertheentirerange
of volumes (Fig. 3). Regression between the phantom (P)
and 4D-MSPECT for the LVEF data was 1.041P+15.976
(R
2 0.968). Regression between the phantom and the QGS
for the LVEF data was 1.140P+2.344 (R
2 0.985). The
relationship between the LVEF data determined by the two
software packages was also linear, with a regression of
QGS=1.057(4D-MSPECT)−12.932 (R
2 0.947). The mean
difference in LVEF between the 4D-MSPECT and QGS
estimates was 9.61±4.35 (p<0.001).
Discussion
In contrast to QGS, which has been compared frequently to
other imaging techniques such as blood-pool imaging and
MRI, 4D-MSPECT seems to be a less well validated tool.
In the present study the performances of QGS and 4D-
MSPECT on both clinical patient data and phantom data
were studied to gain a better understanding of the
relationship between these software packages.
The degree of association
A high degree of correlation and linearity between the
estimates derived from the two software packages has been
found in other studies and by the manufacturers [7, 10–13].
These high correlation values have sometimes been
incorrectly interpreted as a measure of the interchangeability
between QGS and 4D-MSPECT. Therefore, it has to be
stated that correlation is a direct measure of association
rather than of agreement between the packages. If two
methods are compared within a population with large
variation between individuals, which is presented in a
dataset, correlation analysis should be used with caution.
When the variation between two methods is small compared
tothevariationbetween individuals,thecorrelationismainly
determined by the variation within the patient population.
So, in addition to a correlation analysis, a Bland-Altman
analysis was performed to provide a visual representation of
the level of agreement and the presence of bias [14, 15]. If
two systems or methods show total agreement, all measured
values should be situated on the mean line in a Bland-
Altman graph, and this line should coincide with the line of
equality. For excellent, but not total, agreement, the
measured values should be located around the mean line
within a narrow 95% confidence interval. In the Bland-
Altman graphs of the agreement between QGS and 4D-
MSPECT the mean-line was located above the line of
equality (4D-MSPECT=QGS) for all parameters, indicating
higher parameter estimates for 4D-MSPECT than for QGS.
The high level of correlation found in earlier studies can be
explained by the distribution of the calculated values within
wide 95% confidence intervals.
Relationship between QGS and 4D-MSPECT
There were excellent linear relationships between the esti-
mates from the two software packages, and between the
software estimates and the phantom data. Linearity over an
entire range of LVEF values is an important characteristic of a
robustsoftware package. The phantom study further indicated
overestimations of LVEF by both QGS and 4D-MSPECT,
which was more profound in the 4D-MSPECT data.
In a study by Lipke et al. [7], both 4D-MSPECT and
QGS were compared with cardiac MRI. They found a
significant underestimation of EDV by 4D-MSPECT, and
an even higher degree of underestimation by QGS.
However, they found no significant differences between
the software estimates and cardiac MRI for the ESV values.
This result may be explained by the effects of improved
Fig. 3 Linear relationship between the phantom data and QGS
estimates (triangles, solid line) and between the phantom data and
the 4D-MSPECT estimates (circles, dashed line). The dotted line is
the line of equality representing complete agreement between the
phantom data and the software package estimates
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LVEF values, there was a minimal nonsignificant
deviation between 4D-MSPECT and cardiac MRI,
whereas QGS provided a significant underestimation.
These results are supported by the study of Stegger et al.
[13] and Schaefer et al. [11]. Comparing the two packages
with each other, Lipke et al. found significant differences
for the EDV values between the packages, but only small
insignificant differences for the ESV values. In this study
there was a high correlation between the packages for all
three parameters, which is also in agreement with the
studies of Stegger et al. [13] and Schaefer et al. [11].
Nakajima et al. [16] compared data from both a mathe-
matical model of the myocardium and gated blood pool
studies with MPS data obtained by QGS and 4D-MSPECT.
Although high correlations between the software-determined
values and gated blood pool studies were found for LVEF
and EDV, no clear significant difference was found
between the 4D-MSPECT and QGS values. These results
are in contrast with our findings and those of Lipke et al.,
but may be explained by the relatively small number of
patients included (n=30) and the relatively small heart sizes
of these patients.
Important differences between the software algorithms
The general trend to higher estimates provided by 4D-
MSPECT than by QGS found in this study may be
explained by the underlying differences between the
software algorithms. To provide an insight into the differ-
ences, we briefly discuss the basic principles of operation
for the QGS software. This algorithm consists of three main
steps: (1) segmentation of the myocardium, (2) extracting
the mid-myocardial line, and (3) determining the myocar-
dial borders. During segmentation the 3-D position of the
LV within the ungated SPECT acquisition is located, and a
binary mask is made of the heart. A mask is a rough black
and white model indicating the location of the myocardium
in a 3-D space. This binary mask is then used to locate the
mid-myocardial line (the line with the highest count
distribution). An ellipsoid model is fitted and adjusted to
the mid-myocardial line so that it resembles the myocardial
shape. The eventual ellipsoid will serve as a sampling
profile for processing the individual intervals with an
asymmetric gaussian count profile. For every image in the
cardiac cycle the LV cavity is confined by the mitral valve
plane, which is estimated at a 25% threshold of heart
activity in each frame. Eventually an estimate of the
myocardial borders containing holes that represent the
valve plane is obtained for each frame. A more detailed
description of the QGS algorithms is beyond the scope of
this article, but more information can be found in the
literature [17–19].
The 4D-MSPECT software uses the same basic princi-
ples of segmentation, determining the mid-myocardium and
border estimates as are determined by the QGS; however,
there are also some crucial differences [3, 20–22]. First,
4D-MSPECT uses a cylindrical sampling profile within the
basal and mid-ventricular parts of the myocardium and a
spherical profile in the apical part, whereas QGS uses an
ellipsoidal profile throughout the myocardium. This differ-
ence may account for deviations in the estimated LV shape,
especially within the basal regions. Second, 4D-MSPECT
defines the valve plane perpendicular to the long axis, thus
enclosing a part of the outflow tract to the LV volume.
QGS, on the other hand, allows a somewhat oblique valve
plane towards the septum on the long axis, thus excluding a
part of the LV volume near the septum. Additionally, 4D-
MSPECT also allows a basal plane motion of 5–20 mm
towards the apex in systole, whereas QGS uses a fixed
basal plane with a maximum motion that is confined to one
slice. These differences may account for the overestimation
of LVEF, and the relatively smaller difference between the
two software packages during the systolic phase.
Effects of heart size
The multivariate analysis indicated that the factors gender,
BMI, stressor type, average EDVrest and average ESVrest
could explain the differences in parameter values between
the software packages. For this reason the factors gender,
BMI, defect type, heart size and stressor type were used to
create subgroups within the population.
In this study, BMI and stressor type had no particular
effect on the relationship between the software packages.
The factors that did influence the relationship were gender,
defect type and heart size. In the subgroups female gender,
normal perfusion, reversible perfusion defects and small
heart, the differences in LVEF determined by QGS and 4D-
MSPECT were smaller than in the other subgroups tested,
but still significant. This result could possibly be explained
by the smaller sizes of these subgroups. Nonetheless, it
remains apparent that all these subgroups had a relatively
smaller heart size than the other groups. Overall, patients
with a smaller heart size showed a reduced, but still
significant, difference in EDV and ESV, and a small
nonsignificant difference in LVEF, between the two pack-
ages. This may indicate that size affects the calculation of
parameter values differently in the two software packages.
The effects of a small heart size on the values determined
by the QGS software package have also been reported by
others [8–10, 23]. The subdivision of the population in this
study was based on heart size (EDV <70 ml), and presence
or absence of perfusion defects. Although the distribution
method differed from our classification, Lum and Coel [10]
also did not find significant mean differences between the
1742 Eur J Nucl Med Mol Imaging (2010) 37:1736–1744values determined by the two software packages among
patients with a small heart. In the groups with present or
absent perfusion defects, a significant overestimation of
values calculated by 4D-MSPECT in comparison with
those calculated by QGS was found, as in this study.
The partial volume effect, in which one voxel that
should only describe the myocardial wall in fact contains a
mixture of myocardial, LV and extracardiac values, is an
important factor in small hearts. The combination of all
these voxels will result in an overestimation of the actual
size of the myocardial wall, reducing the estimated size of
the LV cavity. As EDVs and especially ESVs, are under-
estimated, a significant overestimation of LVEF values will
occur with decreasing heart size. Factors such as photon
scatter and the relatively low camera resolution may limit
the ability to obtain good border estimates by many
software packages, especially in smaller hearts. In small
hearts each voxel will represent a substantial part of the
myocardial wall, particularly during the systolic phase.
Photon scatter also affects image quality in both small and
larger hearts resulting in blurring of the myocardial borders.
Observations by Hambye et al. indicate that the presence of
scattered photons in the main photo peak is of greater
importance in smaller hearts then in large hearts [24]. So
scatter compensation techniques such as methods base on
the energy window, deconvolution or reconstruction are
especially useful for improving image quality in smaller
hearts [25].
Clinical consequences
Quantitative functional parameters are generally used to
classify a patient with a normal or abnormal myocardial
function in the clinical setting. Some studies that have
provided normal limits for QGS, but there are very few
studies that have provided such limits for 4D-MSPECT.
Normal limits for LVEF calculated by QGS are, according
to Lomsky et al. [26] and Ababneh et al. [27], in the range
of 51–53% for women and 43–47% for men. Based on our
findings, 4D-MSPECT overestimated these values by 4%
on average in poststress and rest acquisitions.
Although estimates of lower normal limits were provid-
ed and good correlations between the software packages
were found, it remains inadvisable to process clinical MPS
data with different software packages. Despite the linearity
of the relationship between the values determined by the
two packages, substantial patient-specific variations in
parameter estimates were also present. Additionally, the
discrepancies between the values provided by these
software packages may have been influenced by heart size.
Consequently, it is extremely difficult to convert the
parameter values for individual patients after transition to
the other software.
In a recent study, Lavender et al. [28] found that other
factors, such as filtering, may also influence the LVEF.
They compared QGS and 4D-MSPECT in 101 patients and
found a good correlation, but there was a clinically
significant difference between the LVEF calculated by the
two packages. In addition, the LVEF was overestimated
using Butterworth filters at cut-off frequencies ≤0.8 cycles/
cm in 26 of 30 patients. The authors concluded that
changing the cut-off frequency by as little as 0.1 cycles/
cm can cause clinically significant differences in the LVEF
estimate. These aspects were not part of our study, but
should definitely be taken into account in clinical practice.
Cardiac MRI is being increasingly used for functional
imaging of the myocardium in clinical practice. In a recent
study by Wang et al. [29], MRI was used as a reference
method to evaluate the software-specific characteristics of
QGS, 4D-MSPECT and the Emory cardiac toolbox (ECTB)
in patients with dilated cardiomyopathy. EDV and ESV
assessed by QGS did not differ significantly from those
assessed by cardiac MRI, whereas ECTB and 4D-MSPECT
overestimated EDV and ESV. In addition, all software
packages overestimated the LVEF compared with MRI.
These findings underline the fact that all modalities and
tools available for quantitative analysis of myocardial
studies will produce different results, which means that
the results are not interchangeable.
Finally, in the present study, administration of adenosine
resulted in a significant mean decrease in LVEF. The exact
mechanism involved in this phenomenon is still unknown and
hasbeenreportedbefore[30], but regarding the data presented
in the tables, it seems to be related to a slight increase in ESV.
Whether this is a direct effect of adenosine or is related to
other factors has to be studied. Nevertheless, as mentioned
before, since both QGS and 4D-MSPECT demonstrated this
phenomenon, there seems to be no relationship with the
software packages used in present study.
Conclusion
In this study we sought a common trend for the differences
in parameter values obtained by 4D-MSPECT and QGS,
and factors that may induce a bias in this relationship.
Although the software packages showed a good correlation,
4D-MSPECT overestimated the values by on average 4%
for the poststress and rest acquisitions compared to values
calculated by QGS. There were excellent linear relation-
ships between the values determined by the two systems
and between the values determined by the two systems and
the phantom data. The differences between the software
package estimates were especially apparent in patients with
normal and increased heart sizes, since deviations between
the system values were greatly influence by heart size. The
discrepancy between the values obtained by the software
Eur J Nucl Med Mol Imaging (2010) 37:1736–1744 1743packages was clinically relevant, and should be taken into
account when a new quantitative software system is
introduced, or when multiple software systems are used in
the same institution.
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